Zynexの資産のリターン
Zynexの資産のリターン は何ですか。
Zynex, Inc.の資産のリターン は14.78%です。
資産のリターン の定義は何ですか。
資産のリターンは 、企業の資産が収益を生み出す際の収益性を示します。純利益を平均総資産で除して計算されます。
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
SSEのセクタHealth Careにおける資産のリターン の企業と比べるZynex
Zynexは何をしますか。
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Zynexと類似の資産のリターン
- Nemetschek SEの資産のリターン は14.77%です。
- Epiroc ABの資産のリターン は14.77%です。
- Epiroc AB (publ)の資産のリターン は14.77%です。
- Atlas Copco ABの資産のリターン は14.78%です。
- Navios Maritime Partners L.Pの資産のリターン は14.78%です。
- Kewaunee Scientificの資産のリターン は14.78%です。
- Zynexの資産のリターン は14.78%です。
- Tapinatorの資産のリターン は14.79%です。
- Oriental Culture LTDの資産のリターン は14.80%です。
- Consun Pharmaceuticalの資産のリターン は14.80%です。
- Zynexの資産のリターン は14.80%です。
- Zynexの資産のリターン は14.80%です。
- Zynexの資産のリターン は14.80%です。